ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$95.6M |
| 2 |
TWOU
2U Inc
TWOU
|
+$43.5M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$43M |
| 4 |
Nutanix
NTNX
|
+$42.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$29.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$97.5M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$52.6M |
| 3 |
Baidu
BIDU
|
+$47.6M |
| 4 |
LendingTree
TREE
|
+$44.9M |
| 5 |
NVIDIA
NVDA
|
+$36.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.31% |
| 2 | Technology | 26.14% |
| 3 | Communication Services | 11.17% |
| 4 | Financials | 10.19% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Netflix
NFLX
$306B
| $43.2M | 1.09% |
1,176,280
-737,470
| -39% | -$26.6M |
|
|
27
LendingTree
TREE
$474M
| $41.6M | 1.05% |
99,017
-117,292
| -54% | -$44.9M |
|
|
28
Nutanix
NTNX
$16.6B
| $36.6M | 0.92% |
1,412,100
+1,224,081
| +651% | +$42.7M |
|
|
SYRS
29
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $35.1M | 0.88% |
379,176
+79,906
| +27% | +$5.56M |
|
30
Compugen
CGEN
$225M
| $32.6M | 0.82% |
8,496,641
+267,086
| +3% | +$945K |
|
31
Pluri
PLUR
$16.8M
| $32M | 0.81% |
64,458
+17,042
| +36% | +$853K |
|
|
32
Meta Platforms (Facebook)
META
$1.5T
| $31.4M | 0.79% |
+162,707
| New | +$29.7M |
|
|
EB
33
DELISTED
Eventbrite
EB
| $26.7M | 0.67% |
1,647,777
+915,824
| +125% | +$17M |
|
34
Alibaba
BABA
$309B
| $25.8M | 0.65% |
152,159
+21,372
| +16% | +$3.69M |
|
35
Seres Therapeutics
MCRB
$50.8M
| $22.7M | 0.57% |
351,944
+87,558
| +33% | +$8.31M |
|
|
XONE
36
DELISTED
The ExOne Company
XONE
| $21.5M | 0.54% |
2,304,554
+133,363
| +6% | +$1.1M |
|
37
Amazon
AMZN
$2.99T
| $21.2M | 0.53% |
223,660
-77,120
| -26% | -$7.18M |
|
38
Iovance Biotherapeutics
IOVA
$1.95B
| $19.8M | 0.5% |
807,688
+116,194
| +17% | +$1.75M |
|
39
Apple
AAPL
$4.52T
| $17.7M | 0.45% |
358,008
-530,536
| -60% | -$25.9M |
|
40
PayPal
PYPL
$50.1B
| $17.4M | 0.44% |
152,299
-14,563
| -9% | -$1.61M |
|
|
CLLS
41
Cellectis
CLLS
$279M
| $17.2M | 0.43% |
1,103,186
+169,110
| +18% | +$3.02M |
|
42
Bristol-Myers Squibb
BMY
$135B
| $16M | 0.4% |
352,421
+158,104
| +81% | +$7.36M |
|
|
BLUE
43
DELISTED
bluebird bio
BLUE
| $13.8M | 0.35% |
8,364
-3,641
| -30% | -$6.3M |
|
44
Pinduoduo
PDD
$130B
| $13.8M | 0.35% |
667,560
+257,821
| +63% | +$5.58M |
|
|
CLDR
45
DELISTED
Cloudera, Inc.
CLDR
| $13.4M | 0.34% |
2,544,376
+1,031,617
| +68% | +$9.52M |
|
46
Inovio Pharmaceuticals
INO
$68.5M
| $11.6M | 0.29% |
329,585
+85,452
| +35% | +$3.39M |
|
47
Incyte
INCY
$24.4B
| $11.1M | 0.28% |
130,737
+63,432
| +94% | +$5.09M |
|
|
VIVS
48
VivoSim Labs
VIVS
$1.28M
| $11.1M | 0.28% |
88,053
+4,725
| +6% | +$893K |
|
|
RUBY
49
DELISTED
Rubius Therapeutics, Inc
RUBY
| $11M | 0.28% |
698,402
+168,787
| +32% | +$2.72M |
|
50
AeroVironment
AVAV
$8.55B
| $10.3M | 0.26% |
181,776
+60,371
| +50% | +$3.97M |
|
Similar funds
ARK Investment Management's Q2 2019 Portfolio in Review
As of Q2 2019, ARK Investment Management held 232 positions worth $3.97B, up 13% from $3.5B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
ARK Investment Management's Q2 2019 filing shows 36 new, 86 increased, 79 reduced and 25 closed positions. Its largest new stake was Meta Platforms (Facebook): 162,707 shares worth $31.4M. The largest sale was Medidata Solutions, Inc., an estimated $97.5M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Communication Services.
- ARK Investment Management's largest Q2 2019 buy was Meta Platforms (Facebook): 162,707 shares worth $31.4M.
- ARK Investment Management added most to Tesla in Q2 2019, an estimated $95.6M increase.
- ARK Investment Management's biggest Q2 2019 reduction was Medidata Solutions, Inc., cutting an estimated $97.5M.
- ARK Investment Management fully exited Zuora, Inc. in Q2 2019, selling an estimated $7.17M.
- ARK Investment Management's ten largest holdings make up 50% of its $3.97B portfolio in Q2 2019.
- ARK Investment Management opened 36 new positions and closed 25 in Q2 2019.
- ARK Investment Management's portfolio value rose 13% quarter-over-quarter to $3.97B.
Based on ARK Investment Management's 13F filing for Q2 2019, filed 30 Jul 2019.